Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Rütgen, Barbara C ^a   Willenbrock, Saskia ^b   Reimann Berg, Nicola ^b   Walter, Ingrid ^a   Fuchs Baumgartinger, Andrea ^a   Wagner, Siegfried ^b   Kovacic, Boris ^a   Essler, Sabine E ^a   Schwendenwein, Ilse ^a   Nolte, Ingo ^b   Saalmüller, Armin ^a   Escobar, Hugo Murua ^b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD79A ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN H; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CELL ACTIVITY; CELL FUNCTION; CELL LINE CLBL 1; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME ABERRATION; CYTOGENETICS; DOG; HISTOPATHOLOGY; IMMUNOPHENOTYPING; IN VIVO STUDY; KARYOTYPE; LYMPHOMA CELL LINE; MOUSE; NONHUMAN; PRECAMBRIAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOGS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION;

ANIMALIA; CANIS FAMILIARIS; MURINAE; MUS;

EID: 84862993855     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040078     Document Type: Article

References (36)

1. Mitsiades CS, Mitsiades NS, Bronson RT, Chauhan D, Munshi N, et al. (2003) Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications. Cancer Res 63: 6689-6696.
2. Khanna C, Lindblad-Toh K, Vail D, London C, Bergman P, et al. (2006) The dog as a cancer model. Nat Biotechnol 24: 1065-1066.
3. Withrow SJ, MacEwen EG, (2001) Small Animal Clinical Oncology. Philadelphia (USA): W.B. Saunders Co. 736 p.
4. Greenlee PG, Filippa DA, Quimby FW, Patnaik AK, Calvano SE, et al. (1990) Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 66: 480-490.
5. Teske E, (1994) Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma. Vet Q 16: 209-219.
6. Fournel-Fleury C, Magnol JP, Bricaire P, Marchal T, Chabanne L, et al. (1997) Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas. J Comp Pathol 117: 35-59.
7. Vail DM, MacEwen EG, (2000) Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 18: 781-792.
8. Breen M, Modiano JF, (2008) Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans-man and his best friend share more than companionship. Chromosome Res 16: 145-154.
9. Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M, (2003) Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer 89: 1530-1537.
10. Starkey MP, Scase TJ, Mellersh CS, Murphy S, (2005) Dogs really are man's best friend-canine genomics has applications in veterinary and human medicine! Brief Funct Genomic Proteomic 4: 112-128.
11. Fosmire SP, Thomas R, Jubala CM, Wojcieszyn JW, Valli VE, et al. (2007) Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet Pathol 44: 467-478.
12. Winkler S, Murua Escobar H, Reimann-Berg N, Bullerdiek J, Nolte I, (2005) Cytogenetic investigations in four canine lymphomas. Anticancer Res 25: 3995-3998.
13. Joetzke AE, Sterenczak KA, Eberle N, Wagner S, Soller JT, et al. (2010) Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases. Vet Comp Oncol 8: 87-95.
14. Sterenczak KA, Joetzke AE, Willenbrock S, Eberle N, Lange S, et al. (2010) High-mobility group B1 (HMGB1) and receptor for advanced glycation end-products (RAGE) expression in canine lymphoma. Anticancer Res 30: 5043-5048.
15. Reimann-Berg N, Murua Escobar H, Kiefer Y, Mischke R, Willenbrock S, et al. (2011) Cytogenetic analysis of CpG-oligonucleotide DSP30 plus Interleukin-2-Stimulated canine B-Cell lymphoma cells reveals the loss of one X Chromosome as the sole abnormality. Cytogenet Genome Res 135: 79-82.
16. Hahn KA, Richardson RC, Hahn EA, Chrisman CL, (1994) Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma. Vet Pathol 31: 528-540.
17. Pastor M, Chalvet-Monfray K, Marchal T, Keck G, Magnol JP, et al. (2009) Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year. J Vet Intern Med 23: 301-310.
18. Rütgen BC, Hammer SE, Gerner W, Christian M, de Arespacochaga AG, et al. (2010) Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma. Leuk Res 34: 932-938.
19. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, et al. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
20. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, et al. (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2: 223-238.
21. Burnett RC, Vernau W, Modiano JF, Olver CS, Moore PF, et al. (2003) Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol 40: 32-41.
22. Kisseberth WC, Nadella MV, Breen M, Thomas R, Duke SE, et al. (2007) A novel canine lymphoma cell line: a translational and comparative model for lymphoma research. Leuk Res 31: 1709-1720.
23. Bartnitzke S, Motzko H, Caselitz J, Kornberg M, Bullerdiek J, et al. (1992) A recurrent marker chromosome involving chromosome 1 in two mammary tumors of the dog. Cytogenet Cell Genet 60: 135-137.
24. Reimann N, Bartnitzke S, Bullerdiek J, Schmitz U, Rogalla P, et al. (1996) An extended nomenclature of the canine karyotype. Cytogenet Cell Genet 73: 140-144.
25. Rütgen BC, Kovacic B, Burger S, Fuchs-Baumgartinger A, Walter I,et al. Tumorgenicity and growth of the canine CLBL-1 cell line in RAG2-/-γc-/-mice - further characterization of a cell line in an in vivo model.; 2011 24-26 March 2011; Glasgow, UK.
26. MacEwen EG, (1990) Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 9: 125-136.
27. Johnson RE, O'Conor GT, Titus W, Hafermann MD, (1969) Comparative clinical, histologic, and radiotherapeutic aspects of canine and human malignant lymphoma. Radiology 93: 395-399.
28. Milner RJ, Pearson J, Nesbit JW, Close P, (1996) Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers. Onderstepoort J Vet Res 63: 309-313.
29. Upanal N, Enjeti A, (2011) Primary lymphoma of the uterus and cervix: two case reports and review of the literature. Aust N Z J Obstet Gynaecol 51: 559-562.
30. Vang R, Medeiros LJ, Ha CS, Deavers M, (2000) Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Mod Pathol 13: 19-28.
31. Bloomfield CD, Arthur DC, Frizzera G, Levine EG, Peterson BA, et al. (1983) Nonrandom chromosome abnormalities in lymphoma. Cancer Res 43: 2975-2984.
32. Devitt JJ, Maranon DG, Ehrhart EJ, Bachand AM, Lana SE, et al. (2009) Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma. Cytogenet Genome Res 124: 12-18.
33. Decker T, Schneller F, Kronschnabl M, Dechow T, Lipford GB, et al. (2000) Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype. Exp Hematol 28: 558-568.
34. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T, (2007) Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 21: 2442-2451.
35. Struski S, Gervais C, Helias C, Herbrecht R, Audhuy B, et al. (2009) Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities. Leukemia 23: 617-619.
36. Saalmüller A, Lunney JK, Daubenberger C, Davis W, Fischer U, et al. (2005) Summary of the animal homologue section of HLDA8. Cell Immunol 236: 51-58.